Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
Download in electronic PDF format for $75
Abstract: Anorectal Crohn’s disease is one of the most problematic and debilitating forms of Crohn’s disease. Crohn’s disease is a type of inflammatory bowel disease that usually affects the intestines but may occur anywhere in the gastrointestinal tract and is frequently refractory to medication, which may ultimately result in proctocolectomy and ileostomy surgeries. It is reported in 3% to 5% of Crohn’s patients and is found in conjunction with colorectal or enteric disease in one-third to one-half of Crohn’s disease patients. This article discusses the use of metronidazole 10% ointment for the treatment of anorectal Crohn’s disease. Since metronidazole is not U.S. Food and Drug Administration approved for treating anorectal Crohn’s disease, and there is no commercially available metronidazole 10% ointment, compounding pharmacists can play a role in providing this dosage form. This article discusses some of the common symptoms of Crohn’s disease and the use of topical metronidazole to treat the disease.
Related Keywords:
metronidazole, formulations, topical preparation, antibiotic, antimicrobial agent, anorectal Crohn's disease, inflammatory bowel disease, anti-inflammatory agents, inflammation, anal fistula plug
Related Categories:
FORMULATIONS, GASTROENTEROLOGY, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
|
Sep/Oct 2013
Pg. 380-383
|
Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
|
Jul/Aug 2003
Pg. 288-291
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Treating Canine Hepatic Disease
Davidson Gigi S
|
May/Jun 2003
Pg. 188-191
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy, Williams LaVonn
|
Jul/Aug 2022
Pg. 293-296
|
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
|
Mar/Apr 2004
Pg. 101-105
|
Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion
Allen Loyd V Jr
|
May/Jun 2022
Pg. 238
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Jones Nat, Carvalho Maria, Branvold-Herr Andrea
|
May/Jun 2017
Pg. 205-211
|
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 57
|
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Goodwin Donald A, Fuhram L Clifton
|
Nov/Dec 1999
Pg. 496-500
|
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
|
Nov/Dec 2022
Pg. 480-488
|
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
|
Mar/Apr 2022
Pg. 94-98
|
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 320
|
Sensitization Therapy for Warts
Kuntz Rachael
|
Jul/Aug 2003
Pg. 266-270
|
Compounding for Treatment of Equine Infectious Diseases: An Overview
Bramwell Bethany L
|
Nov/Dec 2011
Pg. 450-457
|
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drops
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 185
|
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop
Allen Loyd V Jr
|
May/Jun 1999
Pg. 225
|
Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
|
Mar/Apr 2016
Pg. 155-158
|
Return to Top |